Dem Pharmahersteller Formycon DE000A1EWVY8 winkt Geld aus der Vermarktung seines Biosimilars zu Bayers Augenmedikament Eylea in den USA und Kanada.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.